tiprankstipranks
ValiRx PLC (GB:VAL)
LSE:VAL
Holding GB:VAL?
Track your performance easily

ValiRx plc (VAL) Financial Statements

2 Followers

ValiRx plc Financial Overview

ValiRx plc's market cap is currently ―. The company's EPS TTM is p-0.017; its P/E ratio is -0.96; ValiRx plc is scheduled to report earnings on April 15, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 97.70K£ 593.67K£ 1.24M£ 1.85M£ 258.75K
Total Assets£ 3.00M£ 3.52M£ 4.15M£ 4.94M£ 3.80M
Total Debt£ 47.38K£ 58.72K£ 67.27K£ 71.06K£ 243.78K
Net Debt£ -50.32K£ -534.95K£ -1.17M£ -1.78M£ -14.97K
Total Liabilities£ 329.33K£ 109.56K£ 127.77K£ 182.40K£ 1.02M
Stockholders Equity£ 2.87M£ 3.60M£ 4.19M£ 4.91M£ 2.94M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

ValiRx plc Earnings and Revenue History

ValiRx plc Debt to Assets

ValiRx plc Cash Flow

ValiRx plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis